- Home
- PRLD vs WKEY Comparison
PRLD vs WKEY Comparison
Compare PRLD & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- WKEY
- Stock Information
- Founded
- PRLD 2016
- WKEY 1999
- Country
- PRLD United States
- WKEY Switzerland
- Employees
- PRLD N/A
- WKEY N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- WKEY EDP Services
- Sector
- PRLD Health Care
- WKEY Technology
- Exchange
- PRLD Nasdaq
- WKEY Nasdaq
- Market Cap
- PRLD 50.1M
- WKEY 51.9M
- IPO Year
- PRLD 2020
- WKEY N/A
- Fundamental
- Price
- PRLD $0.89
- WKEY $6.22
- Analyst Decision
- PRLD Strong Buy
- WKEY Strong Buy
- Analyst Count
- PRLD 2
- WKEY 1
- Target Price
- PRLD $4.50
- WKEY $4.00
- AVG Volume (30 Days)
- PRLD 137.5K
- WKEY 209.8K
- Earning Date
- PRLD 05-06-2025
- WKEY 06-10-2025
- Dividend Yield
- PRLD N/A
- WKEY N/A
- EPS Growth
- PRLD N/A
- WKEY N/A
- EPS
- PRLD N/A
- WKEY N/A
- Revenue
- PRLD $7,000,000.00
- WKEY $11,875,000.00
- Revenue This Year
- PRLD N/A
- WKEY $18.18
- Revenue Next Year
- PRLD N/A
- WKEY $112.51
- P/E Ratio
- PRLD N/A
- WKEY N/A
- Revenue Growth
- PRLD N/A
- WKEY N/A
- 52 Week Low
- PRLD $0.61
- WKEY $1.61
- 52 Week High
- PRLD $6.80
- WKEY $14.00
- Technical
- Relative Strength Index (RSI)
- PRLD 51.42
- WKEY 57.89
- Support Level
- PRLD $0.77
- WKEY $6.37
- Resistance Level
- PRLD $1.00
- WKEY $7.49
- Average True Range (ATR)
- PRLD 0.11
- WKEY 0.74
- MACD
- PRLD -0.01
- WKEY 0.06
- Stochastic Oscillator
- PRLD 37.18
- WKEY 56.07
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.